TOPRA in Switzerland
Expanding Horizons
TOPRA IN SWITZERLAND
Networking and information meeting in Zürich, June 12, 2012
TOPRA in Switzerland is organizing the third regulatory networking and update meeting in Zürich.
This event is for FREE and aims at all regulatory professionals interested to hear about the latest developments of specific biotechnological regulation, global requirements
on clinical trials and on collaboration to resolve conflicts.
It is the ideal opportunity for regulatory professionals to meet and intensify connections within the pharma industry.
PROGRAM
14:00 – 14:15 Welcome and Introduction
14:15 – 14:45 Prof. Dr. Mühlebach – Non biological complex drugs
14:45 – 15:15 SWISSMEDIC –> TBC
15:15 – 15:45 Coffee/Tea break
15:45 – 16:15 Dr. Frank Wirckx – Global view on the requirements for local clinical trials
16:15 – 16:45 Dr. Ray Harld Puth – Trust, conflict of interst and decision making in collaboration
16:45 – 17:30 NETWORKING
DETAILS
Time:
14:00 - 18:00
Location:
Room Communications
Vifor Pharma, Flughofstrasse 61,
8152 Glattbrugg ( 5 min. form Airport / Kloten train station)
Language:
English
To register for this free event, please go to https://www.topra.org/switzerland12bf
You can also now join the TOPRA In Switzerland Linked In Group
TOPRA's 2nd Networking and Regulatory Update, October 2011
In October 2011, TOPRA organised its second Networking and Regulatory Update meeting to set up its TOPRA in Switzerland group, aimed at bringing together like-minded professionals in Regulatory Affairs,
It was an ideal opportunity to:
- Learn about and become involved with, ‘TOPRA in Switzerland’
- Hear the latest about TOPRA and the latest news on Pharmaceutical and Medical Device regulatory affairs issues.
- Network with colleagues in Switzerland from the regulatory environment in a relaxed and sociable setting.
- Help to identify key initiatives and topics of interest that may form future educational & training events for the region.
Below are the presentations from this event
| Download |
|---|
| new_eu_pharmacovigilance_legislation.pdf |
| article_13_uho.pdf |
| nf_topra_in_switzerland_presentation.pdf |
| topra_111018.pdf |
